Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,784 INR | -0.52% | +5.13% | +8.00% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.00% | 2.78B | |
-22.13% | 7.9B | |
+76.82% | 4.53B | |
-2.80% | 2.64B | |
-50.41% | 1.99B | |
-17.68% | 1.66B | |
-20.23% | 1.49B | |
+19.61% | 1.23B | |
-45.78% | 1.1B | |
+20.25% | 996M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q1; Revenue Meets Estimates